Skip to Content
Merck
All Photos(1)

Key Documents

20832-U

Supelco

ORBO™ 402 Tenax® TA specially treated (35/60), 100/50 mg

W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea

Synonym(s):

ORBO™ Tenax® TA

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12190000
NACRES:
NB.24

material

W,W,W separators

Agency

NIOSH 2507,2545,7905
OSHA 43

product line

ORBO™

composition

Bed A, 100 mg
Bed B, 50 mg

packaging

pkg of 50 ea

manufacturer/tradename

ORBO™ 402

technique(s)

active air sampling: suitable

O.D. × L

8 mm × 100 mm

matrix

Tenax TA (specially treated)

particle size

35-60 mesh

application(s)

air monitoring
environmental
industrial hygiene

Looking for similar products? Visit Product Comparison Guide

General description

ORBO™ 402 Tenax® TA specially treated (35/60), 100/50 mg is a glass tube containing dual-layered beds of the same selective adsorbent separated by glass wool or foam for gas and vapor sampling. This construction of the tube allows for any sample breakthrough to be captured in the smaller backup bed.

It is compatible with gas chromatography-mass spectrometry (GC-MS) equipment and is commonly used for breath analysis applications.

Application

ORBO™ 402 Tenax® TA specially treated (35/60), 100/50 mg has been used as an absorbent for the collection of air samples to determine benzene at trace levels in the environment during the GC/MS analysis.

Legal Information

ORBO is a trademark of Sigma-Aldrich Co. LLC
Tenax is a registered trademark of Buchem B.V.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 3

1 of 3

Supelco

Supelco

11049-U

Tenax® Porous Polymer Adsorbent

Tenax® TA glass TD tube, fritted, O.D. × I.D. × L 6 mm × 4 mm × 4.5 in., preconditioned, 35-60 mesh, pkg of 1 ea

Supelco

20896-U

Tenax® TA

Tenax® TA size 60-80 mesh, glass TD tube (non-fritted), O.D. × L 1/4 in. × 3 1/2 in., preconditioned, 60-80 mesh

Supelco

28715-U

Tenax® TA

[Explorative abrasion--obsolete?].
A Orbo
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 111(19), 2397-2398 (1991-08-20)
Bruno Laeng et al.
Cognitive processing, 12(1), 13-21 (2010-09-25)
We recorded the pupil diameters of participants performing the words' color-naming Stroop task (i.e., naming the color of a word that names a color). Non-color words were used as baseline to firmly establish the effects of semantic relatedness induced by
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service